ELISA Kit for Dopamine Receptor D2 (DRD2)

DR-D2; D2DR; D2R

Specificity

This assay has high sensitivity and excellent specificity for detection of Dopamine Receptor D2 (DRD2).
No significant cross-reactivity or interference between Dopamine Receptor D2 (DRD2) and analogues was observed.

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Dopamine Receptor D2 (DRD2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Front Behav Neurosci Distinct patterns of outcome valuation and amygdala-prefrontal cortex synaptic remodeling in adolescence and adulthood PubMed: 25999830
Behavioural Brain Research Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats Pubmed:27091300
South African Journal of Botany Evaluation of the effect of herbal extracts and their bioactive compounds against motion sickness by regulating neurotransmitter levels in vitro and in vivo
UCLA Electronic Theses and Dissertations Benefit, Burdens and Brain Correlates of Heightened Reward Sensitivity in Adolescence
The GLP-1/GIP dual receptor agonist DA5-CH is superior to Exendin-4 in protecting neurons in the 6-OHDA rat Parkinson Model
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС
JOURNAL OF FOOD BIOCHEMISTRY Menthol, a bioactive constituent of Mentha, attenuates motion sickness in mice model: Involvement of dopaminergic system 34245039
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA673Hu01 Recombinant Dopamine Receptor D2 (DRD2) Positive Control; Immunogen; SDS-PAGE; WB.
RPA673Hu02 Recombinant Dopamine Receptor D2 (DRD2) Positive Control; Immunogen; SDS-PAGE; WB.
PAA673Hu01 Polyclonal Antibody to Dopamine Receptor D2 (DRD2) WB; IHC; ICC; IP.
MAA673Hu22 Monoclonal Antibody to Dopamine Receptor D2 (DRD2) WB; IHC; ICC; IP.
SEA673Hu ELISA Kit for Dopamine Receptor D2 (DRD2) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA673Hu Multiplex Assay Kit for Dopamine Receptor D2 (DRD2) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.